Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data ...
Nirupam even went onto criticise Congress' current leadership, including Mallikarjun Kharge and KC Venugopal, and claimed that they ignored his prior warnings. The senior Shiv Sena leader even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback